These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36462097)

  • 1. Targeting cytokines and signaling molecules related to immune pathways in atopic dermatitis: therapeutic implications and challenges.
    Kim HO
    Arch Pharm Res; 2022 Dec; 45(12):894-908. PubMed ID: 36462097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective.
    David E; Ungar B; Renert-Yuval Y; Facheris P; Del Duca E; Guttman-Yassky E
    Clin Exp Allergy; 2023 Feb; 53(2):156-172. PubMed ID: 36653940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
    Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atopic dermatitis in African American patients is T
    Sanyal RD; Pavel AB; Glickman J; Chan TC; Zheng X; Zhang N; Cueto I; Peng X; Estrada Y; Fuentes-Duculan J; Alexis AF; Krueger JG; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2019 Jan; 122(1):99-110.e6. PubMed ID: 30223113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of biologics in atopic dermatitis.
    Wu J; Guttman-Yassky E
    Expert Opin Biol Ther; 2020 May; 20(5):525-538. PubMed ID: 32003247
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.
    Brunner PM; Guttman-Yassky E; Leung DY
    J Allergy Clin Immunol; 2017 Apr; 139(4S):S65-S76. PubMed ID: 28390479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations.
    Rothenberg-Lausell C; Bar J; Dahabreh D; Renert-Yuval Y; Del Duca E; Guttman-Yassky E
    J Allergy Clin Immunol; 2024 Jul; 154(1):20-30. PubMed ID: 38670231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis.
    Pavel AB; Song T; Kim HJ; Del Duca E; Krueger JG; Dubin C; Peng X; Xu H; Zhang N; Estrada YD; Denis L; Rao N; Gupta S; Zammit DJ; Bissonnette R; Guttman-Yassky E
    J Allergy Clin Immunol; 2019 Oct; 144(4):1011-1024. PubMed ID: 31356921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of atopic dermatitis and selection of immune targets.
    Rothenberg-Lausell C; Bar J; Del Duca E; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2024 Feb; 132(2):177-186. PubMed ID: 38008215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset pediatric atopic dermatitis is T
    Esaki H; Brunner PM; Renert-Yuval Y; Czarnowicki T; Huynh T; Tran G; Lyon S; Rodriguez G; Immaneni S; Johnson DB; Bauer B; Fuentes-Duculan J; Zheng X; Peng X; Estrada YD; Xu H; de Guzman Strong C; Suárez-Fariñas M; Krueger JG; Paller AS; Guttman-Yassky E
    J Allergy Clin Immunol; 2016 Dec; 138(6):1639-1651. PubMed ID: 27671162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK Inhibitors for Atopic Dermatitis: An Update.
    He H; Guttman-Yassky E
    Am J Clin Dermatol; 2019 Apr; 20(2):181-192. PubMed ID: 30536048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.
    Noda S; Suárez-Fariñas M; Ungar B; Kim SJ; de Guzman Strong C; Xu H; Peng X; Estrada YD; Nakajima S; Honda T; Shin JU; Lee H; Krueger JG; Lee KH; Kabashima K; Guttman-Yassky E
    J Allergy Clin Immunol; 2015 Nov; 136(5):1254-64. PubMed ID: 26428954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Janus kinase inhibitors for atopic dermatitis.
    Mikhaylov D; Ungar B; Renert-Yuval Y; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2023 May; 130(5):577-592. PubMed ID: 36736457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?
    Guttman-Yassky E; Krueger JG
    Curr Opin Immunol; 2017 Oct; 48():68-73. PubMed ID: 28869867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging biologic and small molecule therapies for atopic dermatitis.
    Li R; Hadi S; Guttman-Yassky E
    Expert Opin Biol Ther; 2019 Apr; 19(4):367-380. PubMed ID: 30672355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials.
    Yang X; Kambe N; Takimoto-Ito R; Kabashima K
    Pharmacol Ther; 2021 Aug; 224():107830. PubMed ID: 33662453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
    Czarnowicki T; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.
    Orciani M; Campanati A; Caffarini M; Ganzetti G; Consales V; Lucarini G; Offidani A; Di Primio R
    Br J Dermatol; 2017 Jun; 176(6):1569-1576. PubMed ID: 27639070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.